Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Microbiology Simulation on Par With Traditional Wetlab for Pharmacy Students
12/09/2021
Jolynn Tumolo
Use of a virtual simulation or a traditional wetlab resulted in similar outcomes for pharmacy students learning clinical microbiology, leading researchers to conclude that both options are effective.
Use of a virtual simulation or a traditional wetlab resulted in similar outcomes for pharmacy students learning clinical microbiology, leading researchers to conclude that both options are effective.
Use of a virtual simulation or a...
12/09/2021
Pharmacy Learning Network
News
Extended-release Amphetamine Tablet Demonstrates Efficacy for Adult ADHD
12/09/2021
Jolynn Tumolo
An extended-release amphetamine tablet demonstrated efficacy and an anticipated safety profile in adults with ADHD, researchers reported in a poster presentation at Psych Congress 2021.
An extended-release amphetamine tablet demonstrated efficacy and an anticipated safety profile in adults with ADHD, researchers reported in a poster presentation at Psych Congress 2021.
An extended-release amphetamine...
12/09/2021
Psych Congress Network
News
One-Anastomosis Gastric Bypass Best Balances Metabolic Outcomes, Perioperative Safety
12/09/2021
Jolynn Tumolo
In a meta-analysis comparing outcomes among adults undergoing three types of weight loss surgery, one-anastomosis gastric bypass most optimally balanced weight loss and diabetes benefits with risk of complications.
In a meta-analysis comparing outcomes among adults undergoing three types of weight loss surgery, one-anastomosis gastric bypass most optimally balanced weight loss and diabetes benefits with risk of complications.
In a meta-analysis comparing...
12/09/2021
First Report Managed Care
News
Risk Factors Associated With Secondary Extramedullary Multiple Myeloma Development
12/08/2021
Jolynn Tumolo
Younger age, extensive bone disease, and other factors were linked to an increased risk of developing secondary extramedullary multiple myeloma, according to findings published online ahead of print.
Younger age, extensive bone disease, and other factors were linked to an increased risk of developing secondary extramedullary multiple myeloma, according to findings published online ahead of print.
Younger age, extensive bone...
12/08/2021
First Report Managed Care
News
Comparative Effectiveness of Asciminib vs Bosutinib for CML in Chronic Phase
12/07/2021
Jolynn Tumolo
Among patients with chronic myeloid leukemia who had already been treated with at least two tyrosine kinase inhibitors, asciminib resulted in greater major molecular response than bosutinib.
Among patients with chronic myeloid leukemia who had already been treated with at least two tyrosine kinase inhibitors, asciminib resulted in greater major molecular response than bosutinib.
Among patients with chronic...
12/07/2021
First Report Managed Care
News
Generalized Anxiety Disorder Affects 1 in 4 Adults with ADHD
12/06/2021
Jolynn Tumolo
New study results in a nationally representative survey suggest 1 in 4 adults ages 20 to 39 with ADHD also have generalized anxiety disorder.
New study results in a nationally representative survey suggest 1 in 4 adults ages 20 to 39 with ADHD also have generalized anxiety disorder.
New study results in a...
12/06/2021
Psych Congress Network
News
Meta-Analysis Finds Reduced COVID-19 Mortality Risk in Patients With Asthma
12/06/2021
Jolynn Tumolo
A recent meta-analysis that included over 800,000 patients indicated that asthma was significantly associated with reduced mortality risk in patients with COVID-19.
A recent meta-analysis that included over 800,000 patients indicated that asthma was significantly associated with reduced mortality risk in patients with COVID-19.
A recent meta-analysis that...
12/06/2021
First Report Managed Care
News
NSAID Recalled
12/03/2021
Jolynn Tumolo
A Class II recall has been issued for a prescription nonsteroidal anti-inflammatory drug used to alleviate arthritis symptoms.
A Class II recall has been issued for a prescription nonsteroidal anti-inflammatory drug used to alleviate arthritis symptoms.
A Class II recall has been...
12/03/2021
Pharmacy Learning Network
News
Seizure Drug Recalled
12/03/2021
Jolynn Tumolo
The FDA has issued a Class III recall for a prescription medication used to prevent and control seizures and migraines.
The FDA has issued a Class III recall for a prescription medication used to prevent and control seizures and migraines.
The FDA has issued a Class III...
12/03/2021
Pharmacy Learning Network
News
Analgesic Tablets Recalled
12/03/2021
Jolynn Tumolo
A prescription tablet used to treat tension headaches has been recalled due to a labeling error.
A prescription tablet used to treat tension headaches has been recalled due to a labeling error.
A prescription tablet used to...
12/03/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use